DOCSLIB.ORG

NOMESCO Classification of Surgical Procedures

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

NOMESCO Classification of Surgical Procedures NOMESCO Classification of Surgical Procedures 87:2009 Nordic Medico-Statistical Committee (NOMESCO) NOMESCO Classification of Surgical Procedures (NCSP), version 1.14 Organization in charge of NCSP maintenance and updating: Nordic Centre for Classifications in Health Care WHO Collaborating Centre for the Family of International Classifications in the Nordic Countries Norwegian Directorate of Health PO Box 700 St. Olavs plass 0130 Oslo, Norway Phone: +47 24 16 31 50 Fax: +47 24 16 30 16 E-mail: [email protected] Website: www.nordclass.org Centre staff responsible for NCSP maintenance and updating: Arnt Ole Ree, Centre Head Glen Thorsen, Trine Fresvig, Expert Advisers on NCSP Nordic Reference Group for Classification Matters: Denmark: Søren Bang, Ole B. Larsen, Solvejg Bang, Danish National Board of Health Finland: Jorma Komulainen, Matti Mäkelä, National Institute for Health and Welfare Iceland: Lilja Sigrun Jonsdottir, Directorate of Health, Statistics Iceland Norway: Øystein Hebnes, Trine Fresvig, Glen Thorsen, KITH, Norwegian Centre for Informatics in Health and Social Care Sweden: Lars Berg, Gunnar Henriksson, Olafr Steinum, Annika Näslund, National Board of Health and Welfare Nordic Centre: Arnt Ole Ree, Lars Age Johansson, Olafr Steinum, Glen Thorsen, Trine Fresvig © Nordic Medico-Statistical Committee (NOMESCO) 2009 Islands Brygge 67, DK-2300 Copenhagen Ø Phone: +45 72 22 76 25 Fax: +45 32 95 54 70 E-mail: [email protected] Cover by: Sistersbrandts Designstue, Copenhagen Printed by: AN:sats - Tryk & Design a-s, Copenhagen 2008 ISBN 978-87-89702-69-8 PREFACE Preface to NOMESCO Classification of Surgical Procedures Version 1.14 The Nordic Medico-Statistical Committee (NOMESCO) published the first printed edition of the NOMESCO Classification of Surgical Procedures (NCSP) in 1996. Denmark introduced a Danish version of NSCP (NCSP-D) the same year. In 1997, Finland and Sweden introduced national versions (NCSP-F and NCSP-S respectively), whereas Iceland implemented the Nordic (English-language) version of NCSP (NCSP-E). In 1999, Norway adopted a Norwegian version of NCSP (NCSP-N). Thus all five Nordic countries have used NCSP since 1999. A procedure for annual updating of NCSP has been established. The responsibility for updating the classification lies with the Nordic Centre for Classifications in Health Care, in Oslo, Norway. The Centre maintains an electronic discussion group for suggested changes and a Reference group for Nordic classification matters which makes formal recommendations as to changes in the classification. The final decisions are taken by the Board of the Nordic Centre. Information on the NCSP update routine can be found in the section on Structure and classification guidelines. The Nordic version of NCSP has been updated fourteen times. NCSP Version 1.14 is effective from January 1, 2010. NOMESCO and the Nordic Centre decided to make new printed copies of the Nordic version of NCSP available to interested parties on a print-on-demand basis. This version of NCSP 1.14 includes the original preface to the basic Nordic edition of NCSP as well as the guidelines on the structure and use of the classification. The body of the classification incorporates all fourteen updates made so far which have been fully integrated in the text. The first revision consisted mainly of corrections to the original version, whereas later revisions introduce new codes which can be seen as a development of the classification. These changes are based on suggestions from national classification authorities and the discussion in the electronic forum. The changes introduced between the thirteenth and fourteenth revisions are presented in Appendix 2. The changes in the earlier revisions are presented at the website of the Nordic Centre (http://www. nordclass.org). Questions about the maintenance and updating procedure should be directed to the Nordic Centre for Classifications in Health Care. Requests for printed versions of NCSP should be directed to NOMESCO. The classification is also available at the website of the Nordic Centre, from where it can be downloaded in PDF-format (http://www. nordclass.org) Oslo and Copenhagen November 2009 Arnt Ole Ree Johannes Nielsen Head of the Nordic Classification Centre Secretary of NOMESCO 5 PREFACE Preface to first edition At the initiative of NOMESCO, a study comparing surgical frequencies and activities in the Nordic countries was set up in the early 1980’s and resulted, in 1989, in the publication of an abbreviated Nordic list of surgical procedures for Denmark, Finland, Norway and Sweden. Based on the experience gained from this work, it was decided to set up a working group, under NOMESCO, to prepare the structure of a common Nordic classification for surgical procedures. The following persons were appointed as members of the Working Group: Henning Bay-Nielsen, Chairman (Denmark), Peter Sylvest Olsen (Denmark), Timo Niinimäki (Finland) Steffen Birkeland (Noway), Glen Thorsen (Norway), Sven Aschberg (Sweden) (until January 1992), Hubertus van Paaschen (Sweden) (since January 1992) and Björn Smedby (WHO Collaborating Centre for the Classification of Diseases in the Nordic Countries). The Working Group prepared a proposal for a Nordic classification for surgical procedures which was presented and approved at a Nordic seminar in November 1991. At the seminar specialists in each area were appointed to prepare the chapters and as contact persons. In all approximately 100 experts have been associated with the project. The following persons have been responsible for preparing the chapters: Steffen Birkeland and Glen Thorsen (Norway): Structure and classification guidelines Olli Heiskanen (Finland): Chapter A. Nervous system. Arto Sivula (Finland): Chapter B. Endocrine system. Henry Aasved (Norway): Chapter C. Eye and adjacent structures. Magnus Lind (Sweden): Chapter D. Ear, nose and larynx. Pentti Ahonen and Heikki Puhakka (Finland): Chapter E. Teeth, jaws, mouth and pharynx. Odd Geiran (Norway): Chapter F. Heart and major thoracic vessels. Nils B. Fjeld (Norway): Chapter G. Chest wall, pleura, mediastinum, diaphragm, trachea, bronchus and lung. Börje Sundell (Finland): Chapter H. Mammary gland. Glen Thorsen (Norway): Chapter J. Digestive system and spleen. Henning Bay-Nielsen (Denmark): Chapter K. Urinary system, male genital organs and retroperitoneal space. Karin Pihl (Sweden): Chapter L. Female genital organs. Karin Pihl (Sweden): Chapter M. Obstetric procedures. Niels Dieter Röck (Denmark): Chapter N. Musculo-skeletal system. David Bergqvist and Staffan Törngren (Sweden): Chapter P. Peripheral vessels and lymphatic system. Börje Sundell (Finland): Chapter Q. Skin. 6 PREFACE The chapters T, U, X, Y and Z have been prepared by the Editorial Committee, which had the following members: Henning Bay-Nielsen, Chairman (Denmark), Timo Niinimäki (Finland), Jónas Magnússon (Iceland), Steffen Birkeland (Norway) (until July 1995), Glen Thorsen (Norway) (from January 1995) and Hubertus van Paaschen (Sweden). Since the seminar held in November 1991, the Editorial Committee has been responsible for the coordination of final decisions concerning the classification. The Secretary of NOMESCO, Johannes Nielsen, has been Secretary to the Working Group and the Editorial Committee. The translation into English has been undertaken by Glen Thorsen. Henning Bay-Nielsen Chairman of the Editorial Committee 7 CONTENTS Contents Structure and classification guidelines 13 Chapter A Nervous system 22 AA Skull and intracranial structures 22 AB Spinal cord and nerve roots 26 AC Peripheral nerves 28 AD Autonomic nervous system 28 AE Miscellaneous operations on the nervous system 29 AW Reoperations in surgery of the nervous system 29 Chapter B Endocrine system 31 BA Thyroid gland 31 BB Parathyroid gland 32 BC Adrenal gland 32 BD Carotid body 32 BW Reoperations in endocrine surgery 32 Chapter C Eye and adjacent structures 34 CA Orbit 34 CB Eyelid and eyebrow 35 CC Lacrimal apparatus 37 CD Eyeball 38 CE Extraocular muscles 39 CF Conjunctiva 40 CG Cornea and sclera 41 CH Anterior chamber, anterior chamber angle, iris and ciliary body 42 CJ Operations on lens 44 CK Choroid, vitreous body and retina 45 CW Reoperations on eye and adjacent structures 48 Chapter D Ear, nose and larynx 49 DA Auricle 50 DB External auditory canal 50 DC Eardrum and middle ear 50 DD Ossicles of ear 51 DE Mastoid and temporal bone 51 DF Inner ear 51 DG Eustachian tube 52 DH Nose 52 DJ Septum of nose 53 DK Control of epistaxis 53 DL Plastic operations on nose 53 DM Maxillary antrum 53 8 CONTENTS DN Operations on ethmoidal sinus and bone 54 DP Frontal and sphenoidal sinuses 54 DQ Larynx 55 DW Reoperations in surgery of ear, nose and larynx 55 Chapter E Teeth, jaws, mouth and pharynx 57 EA Lips 57 EB Teeth 58 EC Gingiva and alveoli 59 ED Mandible 59 EE Maxilla 60 EF Miscellaneous operations on jaws 61 EG Mandibular joint 62 EH Palate 63 EJ Tongue and floor of mouth 63 EK Cheek 64 EL Salivary glands 65 EM Tonsils and adenoids 66 EN Pharynx and adjacent structures 66 EW Reoperations for complications in surgery of teeth, jaws, mouth and pharynx 67 Chapter F Heart and major thoracic vessels 69 FA Major thoracic veins 70 FB Pulmonary artery with branches 71 FC Thoracic and thoracoabdominal aorta, excluding malformations 74 FD Malformations relating to thoracic aorta 76 FE Pericardium 78 FF Atrium, atrial septum and pulmonary veins 79 FG Tricuspid valve 81 FH Ventricular septum 82 FJ Right ventricle and pulmonary
Recommended publications
  • Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia As a Stand-Alone Procedure Or As a Bridge Toward Liver Transplantation

    Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia As a Stand-Alone Procedure Or As a Bridge Toward Liver Transplantation

    medicina Article Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation Raluca-Cristina Apostu 1, Vlad Fagarasan 1 , Catalin C. Ciuce 1, Radu Drasovean 1 , Dan Gheban 2, Radu Razvan Scurtu 1,*, Alina Grama 3, Ana Cristina Stefanescu 3, Constantin Ciuce 1 and Tudor Lucian Pop 3 1 Department of Surgery, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, 8 Victor Babes Street, 400000 Cluj-Napoca; First Surgical Clinic, Emergency County Hospital, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania; [email protected] or [email protected] (R.-C.A.); [email protected] (V.F.); [email protected] (C.C.C.); [email protected] (R.D.); [email protected] (C.C.) 2 Department of Pathology, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, 8 Victor Babes Street, 400000 Cluj-Napoca; 4 th Pediatric Clinic, Emergency Clinical Hospital for Children, 68 Motilor Street, 400000 Cluj-Napoca, Romania; [email protected] 3 Department of Pediatrics, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, 8 Victor Babes Street, 400000 Cluj-Napoca; 2nd Pediatric Clinic, Emergency Clinical Hospital for Children, 400177 Cluj-Napoca, Romania; [email protected] (A.G.); [email protected] (A.C.S.); [email protected] (T.L.P.) * Correspondence: [email protected]; Tel.: +40-744-704-012 Abstract: Background and objectives: In patients with biliary atresia (BA), hepatoportoenterostomy (HPE) is still a valuable therapeutic tool for prolonged survival or a safer transition to liver transplantation. Citation: Apostu, R.-C.; Fagarasan, V.; The main focus today is towards efficient screening programs, a faster diagnostic, and prompt treatment.
  • Clinical Practice Guideline for Limb Salvage Or Early Amputation

    Clinical Practice Guideline for Limb Salvage Or Early Amputation

    Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline Adopted by: The American Academy of Orthopaedic Surgeons Board of Directors December 6, 2019 Endorsed by: Please cite this guideline as: American Academy of Orthopaedic Surgeons. Limb Salvage or Early Amputation Evidence-Based Clinical Practice Guideline. https://www.aaos.org/globalassets/quality-and-practice-resources/dod/ lsa-cpg-final-draft-12-10-19.pdf Published December 6, 2019 View background material via the LSA CPG eAppendix Disclaimer This clinical practice guideline was developed by a physician volunteer clinical practice guideline development group based on a formal systematic review of the available scientific and clinical information and accepted approaches to treatment and/or diagnosis. This clinical practice guideline is not intended to be a fixed protocol, as some patients may require more or less treatment or different means of diagnosis. Clinical patients may not necessarily be the same as those found in a clinical trial. Patient care and treatment should always be based on a clinician’s independent medical judgment, given the individual patient’s specific clinical circumstances. Disclosure Requirement In accordance with AAOS policy, all individuals whose names appear as authors or contributors to this clinical practice guideline filed a disclosure statement as part of the submission process. All panel members provided full disclosure of potential conflicts of interest prior to voting on the recommendations contained within this clinical practice guideline. Funding Source This clinical practice guideline was funded exclusively through a research grant provided by the United States Department of Defense with no funding from outside commercial sources to support the development of this document.
  • Overexpression of Cx43 in Cells of the Myocardial Scar

    Overexpression of Cx43 in Cells of the Myocardial Scar

    www.nature.com/scientificreports OPEN Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through Received: 27 September 2017 Accepted: 6 April 2018 heterotypic cell-cell coupling Published: xx xx xxxx Wilhelm Roell1, Alexandra M. Klein1,2, Martin Breitbach2, Torsten S. Becker2, Ashish Parikh4, Jane Lee3, Katrin Zimmermann5, Shaun Reining3, Beth Gabris4, Annika Ottersbach1,2, Robert Doran3, Britta Engelbrecht1,2, Miriam Schifer1,2, Kenichi Kimura1,2, Patricia Freitag2, Esther Carls1,2, Caroline Geisen2, Georg D. Duerr1, Philipp Sasse2, Armin Welz1, Alexander Pfeifer5, Guy Salama4, Michael Kotlikof3 & Bernd K. Fleischmann2 Ventricular tachycardia (VT) is the most common and potentially lethal complication following myocardial infarction (MI). Biological correction of the conduction inhomogeneity that underlies re- entry could be a major advance in infarction therapy. As minimal increases in conduction of infarcted tissue markedly infuence VT susceptibility, we reasoned that enhanced propagation of the electrical signal between non-excitable cells within a resolving infarct might comprise a simple means to decrease post-infarction arrhythmia risk. We therefore tested lentivirus-mediated delivery of the gap-junction protein Connexin 43 (Cx43) into acute myocardial lesions. Cx43 was expressed in (myo)fbroblasts and CD45+ cells within the scar and provided prominent and long lasting arrhythmia protection in vivo. Optical mapping of Cx43 injected hearts revealed enhanced conduction velocity within the scar, indicating Cx43-mediated electrical coupling between myocytes and (myo)fbroblasts. Thus, Cx43 gene therapy, by direct in vivo transduction of non-cardiomyocytes, comprises a simple and clinically applicable biological therapy that markedly reduces post-infarction VT. Ventricular tachycardia (VT) is the most common and potentially lethal complication following myocardial infarction (MI)1.
  • Practice Parameters for the Treatment of Patients with Dominantly Inherited Colorectal Cancer

    Practice Parameters for the Treatment of Patients with Dominantly Inherited Colorectal Cancer

    Practice Parameters For The Treatment Of Patients With Dominantly Inherited Colorectal Cancer Diseases of the Colon & Rectum 2003;46(8):1001-1012 Prepared by: The Standards Task Force The American Society of Colon and Rectal Surgeons James Church, MD; Clifford Simmang, MD; On Behalf of the Collaborative Group of the Americas on Inherited Colorectal Cancer and the Standards Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons is dedicated to assuring high quality patient care by advancing the science, prevention, and management of disorders and diseases of the colon, rectum, and anus. The standards committee is composed of Society members who are chosen because they have demonstrated expertise in the specialty of colon and rectal surgery. This Committee was created in order to lead international efforts in defining quality care for conditions related to the colon, rectum, and anus. This is accompanied by developing Clinical Practice Guidelines based on the best available evidence. These guidelines are inclusive, and not prescriptive. Their purpose is to provide information on which decisions can be made, rather than dictate a specific form of treatment. These guidelines are intended for the use of all practitioners, health care workers, and patients who desire information about the management of the conditions addressed by the topics covered in these guidelines. Practice Parameters for the Treatment of Patients With Dominantly Inherited Colorectal Cancer Inherited colorectal cancer includes two main syndromes in which predisposition to the disease is based on a germline mutation that may be transmitted from parent to child.
  • Original Article Characteristics of Incidental Prostate Cancer After Radical Cystoprostatectomy for Bladder Carcinoma in Chinese Men

    Original Article Characteristics of Incidental Prostate Cancer After Radical Cystoprostatectomy for Bladder Carcinoma in Chinese Men

    Int J Clin Exp Pathol 2016;9(3):3743-3750 www.ijcep.com /ISSN:1936-2625/IJCEP0021275 Original Article Characteristics of incidental prostate cancer after radical cystoprostatectomy for bladder carcinoma in Chinese men Guangxiang Liu1, Shiwei Zhang1, Jun Chen2, Xiaozhi Zhao1, Tieshi Liu1, Shuai Zhu1, Qing Zhang1, Weidong Gan1, Xiaogong Li1, Hongqian Guo1 Departments of 1Urology, 2Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Institute of Urology Nanjing University, Nanjing Medical University, Nanjing, Jiangsu, China Received December 6, 2015; Accepted February 15, 2016; Epub March 1, 2016; Published March 15, 2016 Abstract: The purpose of this study was to analyze and characterize the clinicopathological features of incidental prostate cancer (PCa) after radical cystoprostatectomy (RCP) for bladder cancer in Chinese patients. We retrospec- tively reviewed 378 male patients who underwent RCP for muscle invasive bladder cancer at our center and identi- fied 47 men with incidental PCa. The clinicopathological data of incidental PCa after RCP were compared with those of clinical T1c PCas who had radical prostatectomy at our institute. Forty-seven of the 378 patients (12.4%) were diagnosed with PCa. The incidental PCa was well-differentiated in 68.1% of patients, compared to 33.5% of patients with T1c PCa, and was significantly more unifocal than the T1c PCas. When compared to T1c PCa, the incidental PCa was more likely to be organ-confined, have negative margins and be classified as clinically insignificant. After a mean 48-month follow-up, only one patient with incidental PCa was confirmed to have bone metastasis. While 9 patients with clinical T1c PCa were found to have tumor recurrence or metastasis and 5 patients had died caused by PCa.
  • Endoscopy Rotation Coordination and Goals and Objects Department of Surgery Stanford School of Medicine (8/15/17, Jnl)

    Endoscopy Rotation Coordination and Goals and Objects Department of Surgery Stanford School of Medicine (8/15/17, Jnl)

    Endoscopy Rotation Coordination And Goals and Objects Department of Surgery Stanford School of Medicine (8/15/17, jnl) Rotation Director: James Lau, MD ATTENDINGS and CONTACT INFORMATION Cell Phone E-mail Address James Lau, MD (702) 306-8780 [email protected] Homero Rivas, MD MBA (972) 207-2381 [email protected] Dan Azagury, MD (650) 248-3173 [email protected] Shai Friedland, MD [email protected] Andrew Shelton, MD [email protected] Natalie Kirilcuk, MD [email protected] Cindy Kin, MD [email protected] Laren Becker, MD [email protected] Jennifer Pan, MD [email protected] Suzanne Matsui, MD [email protected] Ramsey Cheung, MD [email protected] KEYPOINT The key for this rotation is that you need to show initiative. TEXT Practical Gastrointestinal Endoscopy: The Fundamentals. Sixth Edition. By Peter B. Cotton, Christopher B. Williams, Robert H. Hawes and Brian P. Saunders. You are responsible for the material to enhance your understanding and supplement your past experiences. Lots of pictures and tips and tricks. Quick read. Copy of text available for purchase on Amazon.com or for check out from the Lane Library. Procedure Schedule Monday Tuesday Wednesday Thursday Friday Laren Becker Jennifer Pan Shelton/Kirilcuk/Kin Ramsey Suzanne (VA (VA Colonoscopy 8:00 am Cheung (VA Matsui (VA Livermore) Livermore) (Stanford Endoscopy) Livermore) Livermore) Every other Tuesday Rivas/Lau alternating Upper/Occasional Lower 1 Endoscopy 9a-1p (Stanford Endoscopy) Suzanne Matsui (VA Livermore) The Staff Drs. Becker, Cheung, Pan, and Matsui are gastroenterologists that perform 75% colonoscopies and 25% upper endoscopies at the Livermore location for the Palo Alto VA.
  • Continent Urostomy Guide

    Continent Urostomy Guide

    $POUJOFOU6SPTUPNZ(VJEF "QVCMJDBUJPOPGUIF6OJUFE0TUPNZ"TTPDJBUJPOTPG"NFSJDB *OD i4FJ[FUIF 0QQPSUVOJUZw CONTINENT UROSTOMY GUIDE Ilene Fleischer, MSN, RN, CWOCN, Author Patti Wise, BSN, RN, CWOCN, Author Reviewed by: Authors and Victoria A.Weaver, RN, MSN, CETN Revised 2009 by Barbara J. Hocevar, BSN,RN,CWOCN, Manager, ET/WOC Nursing, Cleveland Clinic © 1985 Ilene Fleischer and Patti Wise This guidebook is available for free, in electronic form, from United Ostomy Associations of America (UOAA). UOAA may be contacted at: www.ostomy.org • [email protected] • 800-826-0826 CONTENTS INTRODUCTION . 3 WHAT IS A CONTINENT UROSTOMY? . 4 THE URINARY TRACT . 4 BEFORE THE SURGERY . .5 THE SURGERY . .5 THE STOMA . 7 AFTER THE SURGERY . 7 Irrigation of the catheter(s) 8 Care of the drainage receptacles 9 Care of the stoma 9 Other important information 10 ROUTINE CARE AT HOME . 10 Catheterization schedule 11 How to catheterize your pouch 11 Special considerations when catheterizing 11 Care of the catheter 12 Other routine care 12 HELPFUL HINTS . .13 SUPPLIES FOR YOUR CONTINENT UROSTOMY . 14 LIFE WITH YOUR CONTINENT UROSTOMY . 15 Clothing 15 Diet 15 Activity and exercise 15 Work 16 Travel 16 Telling others 17 Social relationships 17 Sexual relations and intimacy 17 RESOURCES . .19 GLOSSARY OF TERMS . 20 BIBLIOGRAPHY . .21 1 INTRODUCTION Many people have ostomies and lead full and active lives. Ostomy surgery is the main treatment for bypassing or replacing intestinal or urinary organs that have become diseased or dysfunctional. “Ostomy” means opening. It refers to a number of ways that bodily wastes are re-routed from your body. A urostomy specifi cally redirects urine.
  • Core Neurosurgery

    Core Neurosurgery

    BAYLOR SCOTT & WHITE TEXAS SPINE & JOINT HOSPITAL NEUROLOGICAL SURGERY CLINICAL PRIVILEGES NAME: ________________________________ Initial appointment Reappointment All new applicants must meet the following requirements as approved by the governing body. To be eligible to apply for core privileges in neurological surgery, the initial applicant must meet the following criteria: Successful completion of ACGME or American Osteopathic Association accredited residency in neurological surgery. Required previous experience: Applicants for initial appointment must be able to demonstrate the performance of at least 50 neurological surgical procedures, reflective of the scope of privileges requested, during the last 12 months or demonstrate successful completion of residency or fellowship within the past 12 months. Reappointment requirements: To be eligible to renew core privileges in Neurological Surgery, the applicant must meet the following maintenance of privilege criteria: Current demonstrated competence and an adequate volume of neurological surgery procedures with acceptable results, reflective of the scope of privileges requested, for the past 24 months based on results of ongoing professional practice evaluation and outcomes. Evidence of current ability to perform privileges requested is required of all applicants for renewal of privileges NEUROLOGICAL SURGERY CORE PRIVILEGES Requested: Admit, evaluate, diagnose, consult and provide nonoperative and pre-, intran, and postoperative care to patients of all ages presenting with injuries
  • Tongue and Lip Ties: Best Evidence June 16, 2015

    Tongue and Lip Ties: Best Evidence June 16, 2015

    Tongue and Lip Ties: Best Evidence June 16, 2015 limited elevation in tongue tied baby Tongue and Lip Ties: Best Evidence By: Lee-Ann Grenier Tongue and lip tie (often abbreviated to TT/LT) have become buzzwords among lactation consultants bloggers and new mothers. For many these are strange new words despite the fact that it is a relatively common condition. Treating tongue tie fell out of medical favour in the early 1950s. In breastfeeding circles, it was talked about occasionally, but until recently few health care professionals screened babies for tongue tie and it was frequently overlooked as a cause of common breastfeeding difficulties. In the last few years tongue tie and the related condition lip tie have exploded into the consciousness of mothers and breastfeeding helpers. So why all the fuss about tongue and lip ties all of a sudden? Tongue tie seems to be a relatively common problem, affecting 4-11%1 of the population and it can have a drastic impact on breastfeeding. The presence of tongue tie triples the risk of weaning in the first week of life.2 Here in Alberta it has been challenging to find competent assessment and treatment, prompting several Alberta mothers and their babies to fly to New York in 2011 and 2012 to receive treatment. The dedication and persistence of these mothers has spurred action on providing education and treatment options for Alberta families. In August of 2012, The Breastfeeding Action Committee of Edmonton (BACE) brought Dr. Lawrence Kotlow to Edmonton to provide information and training to area health care providers.
  • Computing in Cardiology

    Computing in Cardiology

    COMPUTING IN CARDIOLOGY September 13-16, 2020 Rimini, Italy Table of Contents Sponsors 3 Welcome to CinC@Rimini in 2020! 5 Board of Directors 7 Local Organizing Committee 8 Letter from the President 9 Welcome to Brno for CinC 2021 10 Maps 11 General Map of Rimini 11 Transportation, Hotels and Practical Information 14 Transportation 14 By air 14 By car 14 By train 14 Local Transportation in Rimini 15 By bus 15 By bike 15 Practical Information 16 Climate 16 Money/currency 16 Emergency phone numbers 16 Electric standards 16 Language 17 Time Zones 17 Mobile Phones 17 Safety and Security 17 COVID-19 emergency – Main general rules in Emilia - Romagna 17 COVID-19 emergency – Safety rules and procedures at Palacongressi 18 Internet Access 19 Computing in Cardiology 2020 1 Meals 20 Accompanying Persons (Guests) 20 Conference Information 21 General Information 21 Sunday Symposium 21 Programme outline 21 Conference site 22 Monday Social Program 23 Activist program 23 Passivist program 24 For Authors and Speakers 25 Oral presentations 25 IN PERSON oral presentations 25 REMOTE oral presentations 26 Q&A during oral presentations 26 Poster presentations 26 IN PERSON poster session 26 REMOTE poster session 27 Rosanna Degani Young Investigator Award 28 Clinical Needs Translational (CTA) Award 28 PhysioNet/Computing in Cardiology Challenge 2020 28 Maastricht Simulation Award (MSA) 29 Deadlines 29 Manuscripts 29 Scientific Program Details 31 Program Overview 2 Computing in Cardiology 2020 Sponsors Computing in Cardiology 2020 is supported by several institutions, companies and academic partnerships. The Local Organizing Committee would like to thank the following partners: Computing in Cardiology 2020 3 4 Computing in Cardiology 2020 Welcome to CinC@Rimini in 2020! Dear Colleagues and Friends, On behalf of the Local Organizing Committee, we warmly welcome you to Computing in Cardiology 2020.
  • Neurosurgery

    Neurosurgery

    KALEIDA HEALTH Name ____________________________________ Date _____________ DELINEATION OF PRIVILEGES - NEUROSURGERY All members of the Department of Neurosurgery at Kaleida Health must have the following credentials: 1. Successful completion of an ACGME accredited Residency, Royal College of Physicians and Surgeons of Canada, or an ACGME equivalent Neurosurgery Residency Program. 2. Members of the clinical service of Neurosurgery must, within five (5) years of appointment to staff, achieve board certification in Neurosurgery. *Maintenance of board certification is mandatory for all providers who have achieved this status* Level 1 (core) privileges are those able to be performed after successful completion of an accredited Neurosurgery Residency program. The removal or restriction of these privileges would require further investigation as to the individual’s overall ability to practice, but there is no need to delineate these privileges individually. PLEASE NOTE: Please check the box for each privilege requested. Do not use an arrow or line to make selections. We will return applications that ignore this directive. LEVEL I (CORE) PRIVILEGES Basic Procedures including: Admission and Follow-Up Repair cranial or dural defect or lesion History and Physical for diagnosis and treatment plan* Seizure Chest tube placement Sterotactic framed localization of lesion Debride wound Sterotactic frameless localization Endotracheal intubation Transsphenoidal surgery of pituitary lesion Excision of foreign body Trauma Insertion of percutaneous arterial
  • Clinical Guideline Experimental Or Investigational Services

    Clinical Guideline Experimental Or Investigational Services

    Clinical Guideline Guideline Number: CG012, Ver. 6 Experimental or Investigational Services Disclaimer Clinical guidelines are developed and adopted to establish evidence-based clinical criteria for utilization management decisions. Oscar may delegate utilization management decisions of certain services to third-party delegates, who may develop and adopt their own clinical criteria. Clinical guidelines are applicable to certain plans. Clinical guidelines are applicable to members enrolled in Medicare Advantage plans only if there are no criteria established for the specified service in a Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) or local coverage determination (LCD) on the date of a prior authorization request. Services are subject to the terms, conditions, limitations of a member’s policy and applicable state and federal law. Please reference the member’s policy documents (e.g., Certificate/Evidence of Coverage, Schedule of Benefits) or contact Oscar at 855-672-2755 to confirm coverage and benefit conditions. Summary The services referenced in this Clinical Guideline are considered experimental or investigational and are therefore not covered by Oscar. The services referenced in this Clinical Guideline may not be all- inclusive. Specific benefit plan documents (e.g., Certificate of Coverage, Schedule of Benefits) and federal or state mandated health benefits and laws take precedence over this Clinical Guideline. A service considered experimental or investigational when its safety and efficacy has been established. They may have outcomes that are inferior to standard medical treatment, for which long-term clinical utility has been established. To determine whether a service, device, treatment or procedure has proven safety and efficacy, the available reliable evidence is reviewed, which may include but is not limited to (listed in order of decreasing reliability): 1.